Whitepaper for healthcare industry investment in the context of "One Belt One Road"

This whitepaper is provided by PwC China’s Healthcare Consulting Team. In light of the "One Belt, One Road" strategy, Asia-pacific region is expected to be an emerging investment destination. With the continuous promotion of the strategy, an increasingly number of overseas investors may access to the greater China Area to invest in the fields of pharmaceuticals, medical technologies and healthcare.

This issue highlights a climbing overseas investment transaction volume and amount made by enterprises based in mainland China and forecast an annualized growth rate of 85%. If you would like to know more about this topic, please refer to PwC China’s webpage or send an email to us.

Contact us

Follow us